

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.44990535 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.44990535 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.15473750 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.15473750 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.63875942 |
| 6 | exogenous drug catabolic process (GO:0042738) | 6.42122323 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.39303329 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.94255485 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.94255485 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.94255485 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.90530954 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.84167383 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.80881525 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.60241901 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.57483031 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54173184 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.54051197 |
| 18 | urea metabolic process (GO:0019627) | 5.48345840 |
| 19 | urea cycle (GO:0000050) | 5.48345840 |
| 20 | omega-hydroxylase P450 pathway (GO:0097267) | 5.43015516 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.34268315 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.32095984 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31836886 |
| 24 | protein carboxylation (GO:0018214) | 5.31836886 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 5.30972501 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.27660318 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.23520196 |
| 28 | cysteine metabolic process (GO:0006534) | 5.19157441 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.04146072 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.03087152 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 4.96755307 |
| 32 | bile acid metabolic process (GO:0008206) | 4.94495376 |
| 33 | regulation of complement activation (GO:0030449) | 4.92798111 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.89824336 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84768063 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.84399294 |
| 37 | oxidative demethylation (GO:0070989) | 4.83576744 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.82621907 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.76981684 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.76981684 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76981684 |
| 42 | lysine catabolic process (GO:0006554) | 4.72385225 |
| 43 | lysine metabolic process (GO:0006553) | 4.72385225 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.72224115 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.67298941 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.63239705 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.61756104 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.61656822 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.61656822 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.61580497 |
| 51 | phospholipid efflux (GO:0033700) | 4.55112351 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.49533829 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.49533829 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.41681219 |
| 55 | coenzyme catabolic process (GO:0009109) | 4.33624552 |
| 56 | glycine metabolic process (GO:0006544) | 4.31272403 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.23935707 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.23905425 |
| 59 | glutamate metabolic process (GO:0006536) | 4.22846435 |
| 60 | drug metabolic process (GO:0017144) | 4.22669608 |
| 61 | imidazole-containing compound metabolic process (GO:0052803) | 4.20338032 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.19852006 |
| 63 | cholesterol efflux (GO:0033344) | 4.17285038 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.14898725 |
| 65 | amine catabolic process (GO:0009310) | 4.14898725 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09281864 |
| 67 | ethanol oxidation (GO:0006069) | 4.08588676 |
| 68 | cellular glucuronidation (GO:0052695) | 4.08473657 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.05113002 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 4.03990688 |
| 71 | ketone body metabolic process (GO:1902224) | 4.01508523 |
| 72 | arginine metabolic process (GO:0006525) | 4.01018380 |
| 73 | arginine catabolic process (GO:0006527) | 3.99614221 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.98790359 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.97753623 |
| 76 | fibrinolysis (GO:0042730) | 3.95413528 |
| 77 | aldehyde catabolic process (GO:0046185) | 3.95338415 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91851855 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 3.88559765 |
| 80 | negative regulation of lipase activity (GO:0060192) | 3.85940062 |
| 81 | ethanol metabolic process (GO:0006067) | 3.85332824 |
| 82 | drug catabolic process (GO:0042737) | 3.84217612 |
| 83 | serine family amino acid biosynthetic process (GO:0009070) | 3.82376017 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81945267 |
| 85 | piRNA metabolic process (GO:0034587) | 3.81150685 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.79504250 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.79259788 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.77773160 |
| 89 | organic acid catabolic process (GO:0016054) | 3.77733509 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.77733509 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77680287 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77680287 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.76124372 |
| 94 | cofactor catabolic process (GO:0051187) | 3.75763147 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.73106740 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69232881 |
| 97 | complement activation (GO:0006956) | 3.67618869 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.66780014 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.66780014 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66534985 |
| 101 | sterol homeostasis (GO:0055092) | 3.66508209 |
| 102 | protein activation cascade (GO:0072376) | 3.66272718 |
| 103 | complement activation, classical pathway (GO:0006958) | 3.66192478 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.62537047 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61837826 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.61140890 |
| 107 | monocarboxylic acid catabolic process (GO:0072329) | 3.58019063 |
| 108 | protein-lipid complex assembly (GO:0065005) | 3.56560271 |
| 109 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54622176 |
| 110 | regulation of meiosis I (GO:0060631) | 3.18554906 |
| 111 | negative regulation of protein activation cascade (GO:2000258) | 3.18008671 |
| 112 | phenylpropanoid metabolic process (GO:0009698) | 3.13123881 |
| 113 | regulation of glucokinase activity (GO:0033131) | 3.11444810 |
| 114 | regulation of hexokinase activity (GO:1903299) | 3.11444810 |
| 115 | alkaloid metabolic process (GO:0009820) | 3.09575893 |
| 116 | regulation of plasminogen activation (GO:0010755) | 3.08641644 |
| 117 | opsonization (GO:0008228) | 3.04882285 |
| 118 | behavioral response to nicotine (GO:0035095) | 3.04778144 |
| 119 | negative regulation of hemostasis (GO:1900047) | 3.03608429 |
| 120 | negative regulation of blood coagulation (GO:0030195) | 3.03608429 |
| 121 | amino acid salvage (GO:0043102) | 2.97914666 |
| 122 | L-methionine salvage (GO:0071267) | 2.97914666 |
| 123 | L-methionine biosynthetic process (GO:0071265) | 2.97914666 |
| 124 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.89152277 |
| 125 | DNA methylation involved in gamete generation (GO:0043046) | 2.86214406 |
| 126 | regulation of humoral immune response (GO:0002920) | 2.81021421 |
| 127 | negative regulation of coagulation (GO:0050819) | 2.80708548 |
| 128 | dopamine transport (GO:0015872) | 2.80486880 |
| 129 | atrial cardiac muscle cell action potential (GO:0086014) | 2.77818999 |
| 130 | cytolysis (GO:0019835) | 2.73977550 |
| 131 | DNA deamination (GO:0045006) | 2.70576659 |
| 132 | peptidyl-glutamic acid modification (GO:0018200) | 2.68156053 |
| 133 | heme transport (GO:0015886) | 2.67889043 |
| 134 | negative regulation of complement activation (GO:0045916) | 2.67531683 |
| 135 | negative regulation of astrocyte differentiation (GO:0048712) | 2.67067687 |
| 136 | kidney morphogenesis (GO:0060993) | 2.66797801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.24207673 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.07498156 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77070056 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41264955 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.29153566 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24300975 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.94541508 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98025673 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.78324225 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.13493843 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.06197383 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73145462 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.55120626 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32688271 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.28854843 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28432033 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25841014 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24576600 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.11873987 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04009528 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7991822 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97113289 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87688539 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.82973458 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80877141 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79563562 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75798828 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68643040 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67656560 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66810428 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66236132 |
| 32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63241429 |
| 33 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.63241429 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62221850 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62007553 |
| 36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61081021 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56232582 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55434536 |
| 39 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.55097697 |
| 40 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51720621 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51017104 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47352041 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47057685 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46058263 |
| 45 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.45535861 |
| 46 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.44892642 |
| 47 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.44095545 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43976787 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41815276 |
| 50 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41692780 |
| 51 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.41692780 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39504301 |
| 53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36133819 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33297192 |
| 55 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31232903 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30356826 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29794815 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27614843 |
| 59 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.27289466 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26704664 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25188014 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22863204 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22588017 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21605813 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21555736 |
| 66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20979629 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20380066 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20318839 |
| 69 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20201145 |
| 70 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.20153396 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20144382 |
| 72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20144382 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20119530 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18198583 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17362276 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17243644 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14983622 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14864399 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14168499 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13544809 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13120008 |
| 82 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13057751 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12406553 |
| 84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12369523 |
| 85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12308930 |
| 86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12267942 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11841926 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11679576 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11185619 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10806365 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.07243443 |
| 92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.06448509 |
| 93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06418574 |
| 94 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05803332 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05803332 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.03495083 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03288799 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03018299 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02916767 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01821498 |
| 101 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99037618 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98927348 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98236576 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97047406 |
| 105 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96559632 |
| 106 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96402755 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96152893 |
| 108 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96058378 |
| 109 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.95649744 |
| 110 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95105718 |
| 111 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94445087 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92738046 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92194572 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90885320 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90056297 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83275590 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79915736 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77084185 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76709538 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73116181 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72832796 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70684107 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68452059 |
| 124 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68421743 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67012675 |
| 126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66582599 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65776857 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65776857 |
| 129 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.63015691 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62460715 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.61786296 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60135952 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.59762166 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59164536 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57823650 |
| 136 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57154731 |
| 137 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56744339 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.56516972 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56225300 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55998006 |
| 141 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55762644 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54874777 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54755070 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54609589 |
| 145 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.53203306 |
| 146 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52876285 |
| 147 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51021442 |
| 148 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.50777061 |
| 149 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.50777061 |
| 150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50761167 |
| 151 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50122451 |
| 152 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50018518 |
| 153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49601432 |
| 154 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48733761 |
| 155 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48452822 |
| 156 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48347643 |
| 157 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48263326 |
| 158 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47742977 |
| 159 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46932154 |
| 160 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46785193 |
| 161 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.45601316 |
| 162 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.45220815 |
| 163 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44269941 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.42751436 |
| 165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42735059 |
| 166 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42515562 |
| 167 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42474453 |
| 168 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.42170408 |
| 169 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41155494 |
| 170 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.40689751 |
| 171 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40111316 |
| 172 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38818443 |
| 173 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38722113 |
| 174 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.38259411 |
| 175 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.37354210 |
| 176 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36545995 |
| 177 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36450975 |
| 178 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36428490 |
| 179 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.35251969 |
| 180 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35137460 |
| 181 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.35029255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17737265 |
| 2 | MP0005360_urolithiasis | 7.38324030 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.39587422 |
| 4 | MP0005365_abnormal_bile_salt | 6.05524276 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06065790 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.22698704 |
| 7 | MP0003252_abnormal_bile_duct | 3.85997157 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57096013 |
| 9 | MP0009840_abnormal_foam_cell | 3.32018992 |
| 10 | MP0005083_abnormal_biliary_tract | 3.03211957 |
| 11 | MP0003195_calcinosis | 2.84398054 |
| 12 | MP0005332_abnormal_amino_acid | 2.74555023 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.48243582 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.41131593 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.27500595 |
| 16 | MP0000609_abnormal_liver_physiology | 2.14617028 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11490267 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.09831480 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.01337685 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.91850603 |
| 21 | MP0003868_abnormal_feces_composition | 1.90556070 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.86652927 |
| 23 | MP0006292_abnormal_olfactory_placode | 1.86550539 |
| 24 | MP0005451_abnormal_body_composition | 1.61030463 |
| 25 | MP0001764_abnormal_homeostasis | 1.60226573 |
| 26 | MP0009697_abnormal_copulation | 1.56969669 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56262978 |
| 28 | MP0003283_abnormal_digestive_organ | 1.53876043 |
| 29 | MP0002102_abnormal_ear_morphology | 1.52348313 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.44871129 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.41400330 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.39564682 |
| 33 | MP0005379_endocrine/exocrine_gland_phen | 1.33871486 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.33698213 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.33537196 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.29256800 |
| 37 | MP0003186_abnormal_redox_activity | 1.28798082 |
| 38 | MP0004043_abnormal_pH_regulation | 1.27945457 |
| 39 | MP0003011_delayed_dark_adaptation | 1.27423806 |
| 40 | MP0003787_abnormal_imprinting | 1.26856190 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.24355887 |
| 42 | MP0004215_abnormal_myocardial_fiber | 1.22884394 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.22697491 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.21713482 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.18759159 |
| 46 | MP0000598_abnormal_liver_morphology | 1.17487924 |
| 47 | MP0002282_abnormal_trachea_morphology | 1.15513712 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.14797267 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.13990983 |
| 50 | MP0005647_abnormal_sex_gland | 1.09790440 |
| 51 | MP0002751_abnormal_autonomic_nervous | 1.09479596 |
| 52 | MP0003136_yellow_coat_color | 1.08727105 |
| 53 | MP0005670_abnormal_white_adipose | 1.08704973 |
| 54 | MP0002938_white_spotting | 1.08387504 |
| 55 | MP0009745_abnormal_behavioral_response | 1.07064289 |
| 56 | MP0002160_abnormal_reproductive_system | 1.06836402 |
| 57 | MP0001968_abnormal_touch/_nociception | 1.05228061 |
| 58 | MP0004133_heterotaxia | 1.03305025 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 1.03245387 |
| 60 | MP0009763_increased_sensitivity_to | 1.01817783 |
| 61 | MP0000604_amyloidosis | 1.01370502 |
| 62 | MP0003122_maternal_imprinting | 1.00976719 |
| 63 | MP0009764_decreased_sensitivity_to | 1.00940269 |
| 64 | MP0004130_abnormal_muscle_cell | 0.99897667 |
| 65 | MP0006276_abnormal_autonomic_nervous | 0.99791271 |
| 66 | MP0005253_abnormal_eye_physiology | 0.97817269 |
| 67 | MP0002163_abnormal_gland_morphology | 0.95868978 |
| 68 | MP0004085_abnormal_heartbeat | 0.95382249 |
| 69 | MP0003137_abnormal_impulse_conducting | 0.93806590 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.93401210 |
| 71 | MP0005410_abnormal_fertilization | 0.91541747 |
| 72 | MP0001502_abnormal_circadian_rhythm | 0.91305130 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.90201095 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.87965732 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.86786444 |
| 76 | MP0002736_abnormal_nociception_after | 0.85800676 |
| 77 | MP0008469_abnormal_protein_level | 0.85467295 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.84423129 |
| 79 | MP0002254_reproductive_system_inflammat | 0.81749425 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 0.81618783 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.80851318 |
| 82 | MP0002272_abnormal_nervous_system | 0.80339473 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.80215260 |
| 84 | MP0005408_hypopigmentation | 0.77853643 |
| 85 | MP0001984_abnormal_olfaction | 0.77751304 |
| 86 | MP0004924_abnormal_behavior | 0.77727543 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.77727543 |
| 88 | MP0005195_abnormal_posterior_eye | 0.77485852 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.77395086 |
| 90 | MP0001929_abnormal_gametogenesis | 0.76468037 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.75201117 |
| 92 | MP0003698_abnormal_male_reproductive | 0.74934623 |
| 93 | MP0002971_abnormal_brown_adipose | 0.74409364 |
| 94 | MP0008995_early_reproductive_senescence | 0.73667777 |
| 95 | MP0005266_abnormal_metabolism | 0.72963162 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.72615948 |
| 97 | MP0002210_abnormal_sex_determination | 0.72166238 |
| 98 | MP0000653_abnormal_sex_gland | 0.71668440 |
| 99 | MP0003119_abnormal_digestive_system | 0.71502334 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.71082471 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70196815 |
| 102 | MP0004142_abnormal_muscle_tone | 0.69355053 |
| 103 | MP0005334_abnormal_fat_pad | 0.68881998 |
| 104 | MP0005187_abnormal_penis_morphology | 0.68742773 |
| 105 | MP0005535_abnormal_body_temperature | 0.68516405 |
| 106 | MP0005389_reproductive_system_phenotype | 0.68349916 |
| 107 | MP0005220_abnormal_exocrine_pancreas | 0.67001957 |
| 108 | MP0003690_abnormal_glial_cell | 0.66693912 |
| 109 | MP0003880_abnormal_central_pattern | 0.66346342 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.64674247 |
| 111 | MP0009046_muscle_twitch | 0.64441414 |
| 112 | MP0001661_extended_life_span | 0.64391121 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.61074093 |
| 114 | MP0009053_abnormal_anal_canal | 0.61013307 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.60473815 |
| 116 | MP0003329_amyloid_beta_deposits | 0.59805671 |
| 117 | MP0001756_abnormal_urination | 0.59023688 |
| 118 | MP0005330_cardiomyopathy | 0.57225497 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.55819597 |
| 120 | MP0002822_catalepsy | 0.54895145 |
| 121 | MP0005448_abnormal_energy_balance | 0.54482559 |
| 122 | MP0008874_decreased_physiological_sensi | 0.47291662 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.45220362 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.44558137 |
| 125 | MP0005395_other_phenotype | 0.43966778 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.42867605 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.42501359 |
| 128 | MP0003724_increased_susceptibility_to | 0.42313834 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.42263089 |
| 130 | MP0008873_increased_physiological_sensi | 0.41391810 |
| 131 | MP0003718_maternal_effect | 0.40691809 |
| 132 | MP0003953_abnormal_hormone_level | 0.40158171 |
| 133 | MP0002269_muscular_atrophy | 0.38662402 |
| 134 | MP0000249_abnormal_blood_vessel | 0.37878832 |
| 135 | MP0002928_abnormal_bile_duct | 0.36969516 |
| 136 | MP0003075_altered_response_to | 0.36240464 |
| 137 | MP0009672_abnormal_birth_weight | 0.35687112 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.35352206 |
| 139 | MP0009115_abnormal_fat_cell | 0.33466604 |
| 140 | MP0008872_abnormal_physiological_respon | 0.33085788 |
| 141 | MP0005166_decreased_susceptibility_to | 0.32734595 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.32711325 |
| 143 | MP0004036_abnormal_muscle_relaxation | 0.32283281 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.31884413 |
| 145 | MP0003646_muscle_fatigue | 0.31541419 |
| 146 | MP0002970_abnormal_white_adipose | 0.31479497 |
| 147 | MP0005385_cardiovascular_system_phenoty | 0.31198461 |
| 148 | MP0001544_abnormal_cardiovascular_syste | 0.31198461 |
| 149 | MP0006138_congestive_heart_failure | 0.31164485 |
| 150 | MP0001243_abnormal_dermal_layer | 0.29399827 |
| 151 | MP0004883_abnormal_blood_vessel | 0.28817282 |
| 152 | MP0000579_abnormal_nail_morphology | 0.28004733 |
| 153 | MP0003436_decreased_susceptibility_to | 0.27298564 |
| 154 | MP0002168_other_aberrant_phenotype | 0.26731432 |
| 155 | MP0004147_increased_porphyrin_level | 0.25823972 |
| 156 | MP0005595_abnormal_vascular_smooth | 0.24723054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.29068166 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17196989 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.05963360 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.36721472 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.35547320 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.26028618 |
| 7 | Xanthomatosis (HP:0000991) | 6.21548324 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.61880195 |
| 9 | Complement deficiency (HP:0004431) | 5.19179359 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.79465756 |
| 11 | Joint hemorrhage (HP:0005261) | 4.64903353 |
| 12 | Hyperammonemia (HP:0001987) | 4.63645455 |
| 13 | Epidermoid cyst (HP:0200040) | 4.42523198 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39582981 |
| 15 | Ketosis (HP:0001946) | 4.37662253 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.31246403 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.30762430 |
| 18 | Hyperglycinemia (HP:0002154) | 4.28413414 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.23894028 |
| 20 | Type II lissencephaly (HP:0007260) | 4.09913688 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.08727699 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.07309894 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.05610350 |
| 24 | Hyperglycinuria (HP:0003108) | 3.95535319 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 3.93031209 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92069882 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.89723979 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89723979 |
| 29 | Fat malabsorption (HP:0002630) | 3.85901543 |
| 30 | Abnormality of complement system (HP:0005339) | 3.76484500 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68492330 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.60987541 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.56113823 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.51175351 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49529301 |
| 36 | Hyperventilation (HP:0002883) | 3.41946254 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.38153732 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.36332451 |
| 39 | Ketoacidosis (HP:0001993) | 3.26097768 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 3.21892862 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 3.21892862 |
| 42 | Pancreatic cysts (HP:0001737) | 3.21278938 |
| 43 | Congenital stationary night blindness (HP:0007642) | 3.17255390 |
| 44 | Nephronophthisis (HP:0000090) | 3.13864938 |
| 45 | Delayed CNS myelination (HP:0002188) | 3.08720254 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 3.07491357 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.99728665 |
| 48 | Fair hair (HP:0002286) | 2.98403357 |
| 49 | Spontaneous abortion (HP:0005268) | 2.96727692 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.95357029 |
| 51 | Retinal atrophy (HP:0001105) | 2.92692380 |
| 52 | Skin nodule (HP:0200036) | 2.92325702 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92258430 |
| 54 | True hermaphroditism (HP:0010459) | 2.91955450 |
| 55 | Cerebellar dysplasia (HP:0007033) | 2.90540096 |
| 56 | Steatorrhea (HP:0002570) | 2.89733324 |
| 57 | Metabolic acidosis (HP:0001942) | 2.88951582 |
| 58 | Myocardial infarction (HP:0001658) | 2.86370958 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.83094108 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83094108 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.77806327 |
| 62 | Abnormality of the renal medulla (HP:0100957) | 2.75486778 |
| 63 | Breast hypoplasia (HP:0003187) | 2.73977120 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.73779874 |
| 65 | Cerebral edema (HP:0002181) | 2.73345009 |
| 66 | Lethargy (HP:0001254) | 2.71312277 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.60110473 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.59581554 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.57893874 |
| 70 | Cholelithiasis (HP:0001081) | 2.55892179 |
| 71 | Chronic hepatic failure (HP:0100626) | 2.52704009 |
| 72 | Acanthocytosis (HP:0001927) | 2.50968302 |
| 73 | Glomerulonephritis (HP:0000099) | 2.49037826 |
| 74 | Mitral stenosis (HP:0001718) | 2.48783287 |
| 75 | Vascular calcification (HP:0004934) | 2.48254551 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.46732654 |
| 77 | Cholecystitis (HP:0001082) | 2.40953749 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.40953749 |
| 79 | Gout (HP:0001997) | 2.40295261 |
| 80 | Abolished electroretinogram (ERG) (HP:0000550) | 2.40129401 |
| 81 | Retinal dysplasia (HP:0007973) | 2.35956227 |
| 82 | Spastic diplegia (HP:0001264) | 2.33751881 |
| 83 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29116682 |
| 84 | Neonatal onset (HP:0003623) | 2.28230487 |
| 85 | Cystic liver disease (HP:0006706) | 2.27607873 |
| 86 | Amyloidosis (HP:0011034) | 2.26400627 |
| 87 | Abnormality of the pons (HP:0007361) | 2.25466566 |
| 88 | Abnormality of the vitreous humor (HP:0004327) | 2.24137527 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.23829967 |
| 90 | Irritability (HP:0000737) | 2.23632913 |
| 91 | Esophageal varix (HP:0002040) | 2.22453062 |
| 92 | Attenuation of retinal blood vessels (HP:0007843) | 2.19680815 |
| 93 | Hypothermia (HP:0002045) | 2.18154676 |
| 94 | Vomiting (HP:0002013) | 2.18097502 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17982526 |
| 96 | Male pseudohermaphroditism (HP:0000037) | 2.17971360 |
| 97 | Hypoplasia of the pons (HP:0012110) | 2.17659719 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.17512781 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.16430758 |
| 100 | Late onset (HP:0003584) | 2.15244243 |
| 101 | Malnutrition (HP:0004395) | 2.14831364 |
| 102 | Gingival bleeding (HP:0000225) | 2.10817703 |
| 103 | Thrombophlebitis (HP:0004418) | 2.08874068 |
| 104 | Pancreatitis (HP:0001733) | 2.08664744 |
| 105 | Poikilocytosis (HP:0004447) | 2.08557716 |
| 106 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08530642 |
| 107 | Tubular atrophy (HP:0000092) | 2.07841175 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07775469 |
| 109 | Abnormal biliary tract physiology (HP:0012439) | 2.07467058 |
| 110 | Bile duct proliferation (HP:0001408) | 2.07467058 |
| 111 | Brushfield spots (HP:0001088) | 2.06299593 |
| 112 | Medial flaring of the eyebrow (HP:0010747) | 2.05532309 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 2.04668857 |
| 114 | Enlarged kidneys (HP:0000105) | 2.03495834 |
| 115 | Abnormality of the gallbladder (HP:0005264) | 2.03427457 |
| 116 | Sclerocornea (HP:0000647) | 2.02690998 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.00887243 |
| 118 | Keratoconus (HP:0000563) | 2.00477329 |
| 119 | Increased corneal curvature (HP:0100692) | 2.00477329 |
| 120 | Menorrhagia (HP:0000132) | 2.00359254 |
| 121 | Abnormal cartilage morphology (HP:0002763) | 1.99281067 |
| 122 | Intestinal atresia (HP:0011100) | 1.98273525 |
| 123 | Scotoma (HP:0000575) | 1.97812646 |
| 124 | Pendular nystagmus (HP:0012043) | 1.96974604 |
| 125 | Lissencephaly (HP:0001339) | 1.95909585 |
| 126 | Microretrognathia (HP:0000308) | 1.91964074 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.91661024 |
| 128 | Generalized hypopigmentation of hair (HP:0011358) | 1.91195589 |
| 129 | Renal cortical cysts (HP:0000803) | 1.90766352 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 1.90690424 |
| 131 | Glycosuria (HP:0003076) | 1.90690424 |
| 132 | Opisthotonus (HP:0002179) | 1.89061949 |
| 133 | Abnormal urine output (HP:0012590) | 1.88833292 |
| 134 | Hyperglycemia (HP:0003074) | 1.88571379 |
| 135 | Polyuria (HP:0000103) | 1.86617117 |
| 136 | Decreased central vision (HP:0007663) | 1.86550151 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85234346 |
| 138 | Disproportionate short-trunk short stature (HP:0003521) | 1.83173227 |
| 139 | Rickets (HP:0002748) | 1.81672291 |
| 140 | Acute encephalopathy (HP:0006846) | 1.81510848 |
| 141 | Reticulocytosis (HP:0001923) | 1.81300126 |
| 142 | Polydipsia (HP:0001959) | 1.80565730 |
| 143 | Abnormal drinking behavior (HP:0030082) | 1.80565730 |
| 144 | Elevated hepatic transaminases (HP:0002910) | 1.79294756 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.77602839 |
| 146 | Hypophosphatemic rickets (HP:0004912) | 1.77555440 |
| 147 | Abnormality of proline metabolism (HP:0010907) | 1.77277660 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.77277660 |
| 149 | Nephritis (HP:0000123) | 1.77103547 |
| 150 | Acute hepatic failure (HP:0006554) | 1.76978097 |
| 151 | Chorioretinal atrophy (HP:0000533) | 1.75630947 |
| 152 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75529222 |
| 153 | Myoglobinuria (HP:0002913) | 1.74100342 |
| 154 | Prominent supraorbital ridges (HP:0000336) | 1.73839240 |
| 155 | Congenital hepatic fibrosis (HP:0002612) | 1.72460735 |
| 156 | Severe visual impairment (HP:0001141) | 1.69956795 |
| 157 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.64338408 |
| 158 | Dandy-Walker malformation (HP:0001305) | 1.64315451 |
| 159 | Acute necrotizing encephalopathy (HP:0006965) | 1.63039448 |
| 160 | Mesangial abnormality (HP:0001966) | 1.62221200 |
| 161 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.61755043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.15177953 |
| 2 | ACVR1B | 4.51247343 |
| 3 | FGFR4 | 4.24047268 |
| 4 | SIK1 | 4.22367168 |
| 5 | ERN1 | 3.96126813 |
| 6 | BMPR1B | 3.76602481 |
| 7 | CASK | 3.68582729 |
| 8 | PKN2 | 3.06394661 |
| 9 | INSRR | 2.67838962 |
| 10 | ERBB4 | 2.58177147 |
| 11 | TAOK3 | 2.46079289 |
| 12 | TLK1 | 2.43680469 |
| 13 | TRIB3 | 2.26927241 |
| 14 | ZAK | 2.25010572 |
| 15 | MAP4K2 | 2.20771145 |
| 16 | MAP2K4 | 2.12832244 |
| 17 | FLT3 | 2.10030547 |
| 18 | PNCK | 2.08592431 |
| 19 | ADRBK2 | 2.02510156 |
| 20 | WNK3 | 1.99158638 |
| 21 | NUAK1 | 1.92285707 |
| 22 | MST1R | 1.80646582 |
| 23 | MKNK2 | 1.78219435 |
| 24 | MAPK11 | 1.77245609 |
| 25 | TGFBR1 | 1.72618765 |
| 26 | NEK9 | 1.67217269 |
| 27 | KDR | 1.62836869 |
| 28 | PINK1 | 1.61507734 |
| 29 | STK39 | 1.56940988 |
| 30 | MAPK13 | 1.52665791 |
| 31 | TYK2 | 1.51876356 |
| 32 | DAPK2 | 1.49818781 |
| 33 | TIE1 | 1.49437805 |
| 34 | PIK3CG | 1.48530865 |
| 35 | LATS1 | 1.46723247 |
| 36 | WNK4 | 1.40305772 |
| 37 | PTK6 | 1.39663783 |
| 38 | MAP3K4 | 1.39604126 |
| 39 | MAP3K7 | 1.35133511 |
| 40 | ABL2 | 1.35090159 |
| 41 | MARK3 | 1.33999939 |
| 42 | OXSR1 | 1.29566367 |
| 43 | MUSK | 1.27417284 |
| 44 | BRSK2 | 1.22867482 |
| 45 | NTRK3 | 1.21386215 |
| 46 | PRKAA2 | 1.20266726 |
| 47 | JAK2 | 1.15837768 |
| 48 | TNIK | 1.10668222 |
| 49 | PLK4 | 1.10394214 |
| 50 | MAP2K3 | 1.09373664 |
| 51 | RIPK1 | 1.04909989 |
| 52 | ADRBK1 | 1.03186453 |
| 53 | WEE1 | 1.01766940 |
| 54 | TBK1 | 1.01721856 |
| 55 | PRKCE | 1.00608827 |
| 56 | STK38L | 0.99933108 |
| 57 | MYLK | 0.99686839 |
| 58 | MAPK4 | 0.99006428 |
| 59 | FGFR2 | 0.97771900 |
| 60 | MARK1 | 0.97327200 |
| 61 | MAP3K11 | 0.96632674 |
| 62 | MAPK15 | 0.96504165 |
| 63 | MAPK12 | 0.93439217 |
| 64 | CAMK1G | 0.92806439 |
| 65 | PDK4 | 0.90918870 |
| 66 | PDK3 | 0.90918870 |
| 67 | JAK1 | 0.90575095 |
| 68 | IRAK1 | 0.90504645 |
| 69 | NTRK2 | 0.90283668 |
| 70 | OBSCN | 0.89286438 |
| 71 | ERBB2 | 0.87964898 |
| 72 | NME1 | 0.87078219 |
| 73 | MAP3K3 | 0.86831606 |
| 74 | MET | 0.86153171 |
| 75 | PRKCZ | 0.84671098 |
| 76 | PLK2 | 0.81425481 |
| 77 | EPHB1 | 0.80749765 |
| 78 | PRKACG | 0.80442821 |
| 79 | STK11 | 0.79269148 |
| 80 | GRK6 | 0.79258470 |
| 81 | CAMK2G | 0.78737186 |
| 82 | MAP3K10 | 0.77709957 |
| 83 | PRKAA1 | 0.76606495 |
| 84 | TTN | 0.76184898 |
| 85 | PIK3CA | 0.75696659 |
| 86 | VRK1 | 0.74604614 |
| 87 | FRK | 0.72601327 |
| 88 | CAMK1D | 0.72168390 |
| 89 | TGFBR2 | 0.71798401 |
| 90 | KIT | 0.70220742 |
| 91 | PHKG2 | 0.69741186 |
| 92 | PHKG1 | 0.69741186 |
| 93 | FER | 0.68750993 |
| 94 | PRKG1 | 0.68555418 |
| 95 | CAMK4 | 0.68420997 |
| 96 | PRKCI | 0.68332561 |
| 97 | CAMK1 | 0.68086637 |
| 98 | CAMKK1 | 0.65530826 |
| 99 | GSK3A | 0.65044216 |
| 100 | CDK6 | 0.65003567 |
| 101 | MAP3K5 | 0.64986827 |
| 102 | MAPK7 | 0.64582380 |
| 103 | STK3 | 0.63203696 |
| 104 | EPHA3 | 0.63045332 |
| 105 | SGK3 | 0.62354055 |
| 106 | AKT3 | 0.61475849 |
| 107 | PRKACA | 0.61247781 |
| 108 | CSK | 0.61226310 |
| 109 | CAMK2A | 0.58053040 |
| 110 | MAP2K7 | 0.54802120 |
| 111 | PDPK1 | 0.54247760 |
| 112 | MAP3K14 | 0.53978376 |
| 113 | PTK2 | 0.53173904 |
| 114 | MST4 | 0.52530269 |
| 115 | PKN1 | 0.52494591 |
| 116 | PRKCQ | 0.50946220 |
| 117 | MAP2K6 | 0.49803307 |
| 118 | PAK3 | 0.49387778 |
| 119 | EPHB2 | 0.49059668 |
| 120 | NLK | 0.48532143 |
| 121 | RET | 0.48309593 |
| 122 | MKNK1 | 0.48133289 |
| 123 | EIF2AK3 | 0.48048566 |
| 124 | CSNK1A1 | 0.47988283 |
| 125 | MAP2K2 | 0.47812210 |
| 126 | MAP3K6 | 0.47390030 |
| 127 | CDK3 | 0.46956084 |
| 128 | PDGFRA | 0.46722775 |
| 129 | FGFR3 | 0.46720799 |
| 130 | TRIM28 | 0.45925193 |
| 131 | CAMKK2 | 0.45039626 |
| 132 | DYRK1B | 0.45004204 |
| 133 | MAP2K1 | 0.44835207 |
| 134 | IRAK3 | 0.42575877 |
| 135 | SGK2 | 0.42428366 |
| 136 | CDK4 | 0.42189750 |
| 137 | PLK3 | 0.41237951 |
| 138 | ICK | 0.40323187 |
| 139 | IKBKE | 0.39420282 |
| 140 | TNK2 | 0.38796430 |
| 141 | PRKD1 | 0.38538186 |
| 142 | TEC | 0.37426504 |
| 143 | PIM1 | 0.36981584 |
| 144 | ROCK1 | 0.36638682 |
| 145 | MTOR | 0.36401012 |
| 146 | IGF1R | 0.36386417 |
| 147 | DYRK2 | 0.36379221 |
| 148 | CSNK1D | 0.36089273 |
| 149 | CSF1R | 0.36031415 |
| 150 | CSNK1G1 | 0.36012314 |
| 151 | TXK | 0.35465178 |
| 152 | PRKG2 | 0.35159553 |
| 153 | PTK2B | 0.34658725 |
| 154 | PDK2 | 0.33920361 |
| 155 | EPHA4 | 0.31651845 |
| 156 | NEK1 | 0.31567795 |
| 157 | PDK1 | 0.30969307 |
| 158 | SGK494 | 0.30319348 |
| 159 | SGK223 | 0.30319348 |
| 160 | EGFR | 0.29247177 |
| 161 | GRK1 | 0.28742072 |
| 162 | MAP3K1 | 0.28188220 |
| 163 | LATS2 | 0.27937022 |
| 164 | PRKCG | 0.27582038 |
| 165 | PRKACB | 0.26874389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39596154 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51555127 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45656647 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24362355 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05824329 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72327329 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71843532 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67957872 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66887849 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63534782 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50226674 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49104240 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18252178 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17042924 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10306015 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08472031 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07116257 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92698368 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92615484 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88526114 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85591880 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83310729 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83176942 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73626326 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72070252 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71278374 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70440556 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68146387 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66994042 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65805231 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64246728 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61781774 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58419432 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53137278 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49686385 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46122218 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.45210406 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44188016 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43359753 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31147524 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31063619 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30560428 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27223298 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23681363 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.20231248 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.14784058 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14713934 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14412035 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08795547 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03341754 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03303496 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02277808 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00593557 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.94533891 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91611724 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88328162 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87833569 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86695738 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86556754 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86407256 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85742376 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.82572179 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81806998 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80963499 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.79847329 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78609699 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77489132 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67345094 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66068534 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65041834 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64188744 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.63505690 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57927403 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56592933 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53061592 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.47480790 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47464398 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47449152 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46217506 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44980261 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40165039 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35304128 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33517382 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33363302 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.33094834 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30729788 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.30544424 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.30517241 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30477731 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30357139 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.28622791 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27619392 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26432654 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24182985 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.24045203 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23910043 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23126291 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.22978391 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22100715 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19958847 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.19249671 |
| 102 | GABAergic synapse_Homo sapiens_hsa04727 | 0.18573286 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18213121 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16118337 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15820806 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15231808 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12393008 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04908630 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2263480 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2252790 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | -0.2230651 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2201265 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2155067 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | -0.2103687 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2023352 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1920834 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1897755 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1748955 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1683700 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1672475 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1563173 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1535005 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1361538 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1125717 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1041251 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0829526 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0507457 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0353231 |

